Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.